Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.
Moximed springs to $33m Series B round
Gilde Healthcare Partners
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.
